Literature DB >> 16544443

Intragastric balloons: a temporary treatment for obesity.

C Allison.   

Abstract

(1) Intragastric balloons are a temporary non-surgical obesity treatment that induces short-term weight loss by partially filling the stomach to achieve satiety and reduce food intake. (2) Moderate weight loss may be achieved if patients adhere to a weight-reduction program. Weight gain often recurs when the balloon is removed after six months. (3) Abdominal pain, nausea, and vomiting are common, particularly in the first week after balloon implantation. (4) More data on benefits, harm, and cost effectiveness are required before the intragastric balloon can be compared with other short-term weight loss interventions, including low-calorie diets.

Entities:  

Mesh:

Year:  2006        PMID: 16544443

Source DB:  PubMed          Journal:  Issues Emerg Health Technol        ISSN: 1488-6316


  4 in total

1.  Effectiveness and safety of air-filled balloon Heliosphere BAG® in 82 consecutive obese patients.

Authors:  Edurne Lecumberri; Waeel Krekshi; Pilar Matía; Carlos Hermida; Nuria García de la Torre; Lucio Cabrerizo; Miguel Ángel Rubio
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

2.  Gastric electrical stimulation optimized to inhibit gastric motility reduces food intake in dogs.

Authors:  Geng-Qing Song; Hongbing Zhu; Yong Lei; Charlene Yuan; Warren Starkebaum; Jieyun Yin; Jiande D Z Chen
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

3.  Preoperative weight loss with intragastric balloon decreases the risk of significant adverse outcomes of laparoscopic gastric bypass in super-super obese patients.

Authors:  Carlos Zerrweck; Vincent Maunoury; Robert Caiazzo; Julien Branche; Guélareh Dezfoulian; Philippe Bulois; Helene Verkindt; Marie Pigeyre; Laurent Arnalsteen; François Pattou
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 4.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.